ref | material | size | size err | size unit | size type | size comment | BET | b nanozyme | b 10n | b unit | specific act | sa 10n | sa unit | comment | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7670 | 440 | PEG-Au/FeMOF@CPT NPs | 50 | nm | TEM | Monodispersed nanoparticles with the diameter around 50 nm were observed in transmission electron microscopy (TEM) image (Figure 1a and Figure S1, Supporting Information). Au/FeMOF NPs were further fabricated using FeMOF NPs as platforms by directly reducing HAuCl4 in water using sodium borohydride as a reductant. As shown in Figure 1b,d, dark spots corresponding to the Au NPs ≈5 nm in diameter were observed on the exterior surface of Au/FeMOF NPs. | 1451 |
ref | material | enzyme type | substrate | pH | T | km | km err | km 10n | km unit | vmax | vmax err | vmax 10n | vmax unit | kcat | kcat err | kcat 10n | kcat unit | kcat/km | kcat/km 10n | kcat/km unit | comment |
---|
ref | material | application | target | method | linear range | linear ran unit | LOD | lod unit | recovery | comment | |
---|---|---|---|---|---|---|---|---|---|---|---|
5352 | 440 | PEG-Au/FeMOF@CPT NPs | Cancer Therapy | ||||||||
5351 | 440 | PEG-Au/FeMOF@CPT NPs | Cancer Therapy | Triggered by the high concentration of phosphate inside the cancer cells, Au/FeMOF@CPT NPs effectively collapse after internalization, resulting in the complete drug release and activation of the cascade catalytic reactions. |
ref | title | DOI | material type | comment | |
---|---|---|---|---|---|
3628 | 440 | A Nanomedicine Fabricated from Gold Nanoparticles‐Decorated Metal–Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy | https://doi.org/10.1002/advs.202001060 | Composite | metal–organic framework (MOF) nanoparticles and gold nanoparticles (Au NPs)(PEG-Au/FeMOF@CPT NPs) |